Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection